CervoMed - 53 Year Dividend History | CRVO
Historical dividend payout and yield for CervoMed (CRVO) since 1971. The current TTM dividend payout for CervoMed (CRVO) as of December 20, 2024 is $0.00. The current dividend yield for CervoMed as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.007B |
|
CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase alpha. CervoMed Inc., formerly known as Diffusion Pharmaceuticals Inc., is based in BOSTON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
